1 |
Elfadadny A, Ragab RF, Hamada R, Al Jaouni SK, Fu J, Mousa SA, El-far AH. Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: Anticancer efficacy and safety. Toxicology and Applied Pharmacology 2023. [DOI: 10.1016/j.taap.2023.116405] [Reference Citation Analysis]
|
2 |
Liu W, Cheng M, Lu Z, Li H, Feng Y, Jin Y, Yang S, Feng J, Tu L. Multi-functional chitosan copolymer modified nanocrystals as oral andrographolide delivery systems for enhanced bioavailability and anti-inflammatory efficacy. Drug Deliv 2022;29:3432-42. [PMID: 36447367 DOI: 10.1080/10717544.2022.2149894] [Reference Citation Analysis]
|
3 |
Shen Y, Guo K, Ma A, Huang Z, Du J, Chen J, Lin Q, Wei C, Wang Z, Zhang F, Zhang J, Lin W, Feng N, Ma W. Mitochondrial toxicity evaluation of traditional Chinese medicine injections with a dual in vitro approach. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1039235] [Reference Citation Analysis]
|
4 |
Cheon C, Ko S. Synergistic effects of natural products in combination with anticancer agents in prostate cancer: A scoping review. Front Pharmacol 2022;13:963317. [DOI: 10.3389/fphar.2022.963317] [Reference Citation Analysis]
|
5 |
Shen Y, Guo K, Ma A, Huang Z, Du J, Chen J, Lin Q, Wei C, Wang Z, Zhang F, Zhang J, Lin W, Feng N, Ma W. A dual in vitro approach for systematic analysis of mitochondrial toxicity in traditional Chinese medicine injections.. [DOI: 10.21203/rs.3.rs-1995245/v1] [Reference Citation Analysis]
|